Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | - AUD | -100.0% |
| 2023 | 1.18 Million AUD | -40.03% |
| 2022 | 1.98 Million AUD | 29.33% |
| 2021 | 1.53 Million AUD | 4380.44% |
| 2020 | 34.22 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 30.3 Thousand AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.22 Million AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2024 Q1 | 1.22 Million AUD | 522.21% |
| 2024 Q4 | - AUD | 0.0% |
| 2023 FY | 1.18 Million AUD | -40.03% |
| 2023 Q2 | 884.69 Thousand AUD | -0.0% |
| 2023 Q3 | -289.94 Thousand AUD | -132.77% |
| 2023 Q4 | -289.94 Thousand AUD | 0.0% |
| 2023 Q1 | 884.69 Thousand AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 FY | 1.98 Million AUD | 29.33% |
| 2022 Q2 | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 FY | 1.53 Million AUD | 4380.44% |
| 2020 Q4 | - AUD | 0.0% |
| 2020 FY | 34.22 Thousand AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 FY | - AUD | -100.0% |
| 2015 FY | 30.3 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |